Scott D.L., Symmons D.P., Coulton B.L., et al. Long-term outcome of treating rheumatoid arthritis: results after 20 years. Lancet 1 8542 (1987) 1108-1111
O'Dell J.R. Therapeutic strategies for rheumatoid arthritis [see comment]. N Engl J Med 350 25 (2004) 2591-2602
van der Heijde D.M. Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol 34 Suppl 2 (1995) 74-78
Ostergaard M., Ejbjerg B., and Szkudlarek M. Imaging in early rheumatoid arthritis: roles of magnetic resonance imaging, ultrasonography, conventional radiography and computed tomography. Best Pract Res Clin Rheumatol 19 1 (2005) 91-116
Backhaus M., Burmester G.R., Sandrock D., et al. Prospective two year follow up study comparing novel and conventional imaging procedures in patients with arthritic finger joints. Ann Rheum Dis 61 10 (2002) 895-904
Fogelman I. Bone scanning. In: Maisey M.N., Britton K.E., and Gilday D.L. (Eds). Clinical nuclear medicine (1991), Chapman and Hall Medical, London 131-157
Polisson R.P., Schoenberg O.I., Fischman A., et al. Use of magnetic resonance imaging and positron emission tomography in the assessment of synovial volume and glucose metabolism in patients with rheumatoid arthritis. Arthritis Rheum 38 6 (1995) 819-825
Palmer W.E., Rosenthal D.I., Schoenberg O.I., et al. Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 196 3 (1995) 647-655
Roivainen A., Parkkola R., Yli-Kerttula T., et al. Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium. Arthritis Rheum 48 11 (2003) 3077-3084
Beckers C., Ribbens C., Andre B., et al. Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. J Nucl Med 45 6 (2004) 956-964
Beckers C., Jeukens X., Ribbens C., et al. (18)F-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3. Eur J Nucl Med Mol Imaging 33 (2006) 245-280
Fischman A.J., and Alpert N.M. FDG-PET in oncology: there's more to it than looking at pictures. J Nucl Med 34 1 (1993) 6-11
Hamberg L.M., Hunter G.J., Alpert N.M., et al. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification?. J Nucl Med 35 8 (1994) 1308-1312
Boerner A.R., Weckesser M., Herzog H., et al. Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer. Eur J Nucl Med 26 3 (1999) 226-230
Lodge M.A., Lucas J.D., Marsden P.K., et al. PET study of 18FDG uptake in soft tissue masses. Eur J Nucl Med 26 1 (1999) 22-30
Hustinx R., Smith R.J., Benard F., et al. Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck. Eur J Nucl Med 26 10 (1999) 1345-1348
Yamada S., Kubota K., Kubota R., et al. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 36 7 (1995) 1301-1306
Beckers C., Bernard C., Kaiser M.J., et al. Time-course study of FDG uptake in psoriasic synovitis. J Nucl Med 46 Suppl 2 (2005) 183P
Zhao S., Kuge Y., Tsukamoto E., et al. Effects of insulin and glucose loading on FDG uptake in experimental malignant tumours and inflammatory lesions. Eur J Nucl Med 28 6 (2001) 730-735
Zhao S., Kuge Y., Tsukamoto E., et al. Fluorodeoxyglucose uptake and glucose transporter expression in experimental inflammatory lesions and malignant tumours: effects of insulin and glucose loading. Nucl Med Commun 23 6 (2002) 545-550
Brix G., Lechel U., Glatting G., et al. Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations. J Nucl Med 46 4 (2005) 608-613
Brenner W. 18F-FDG PET in rheumatoid arthritis: there still is a long way to go [comment]. J Nucl Med 45 6 (2004) 927-929
Heelan B.T., Osman S., Blyth A., et al. Use of 2-[18F]fluoro-2-deoxyglucose as a potential agent in the prediction of graft rejection by positron emission tomography. Transplantation 66 8 (1998) 1101-1103
Yamada S., Kubota K., Kubota R., et al. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 36 7 (1995) 1301-1306
Ishimori T., Saga T., Mamede M., et al. Increased (18)F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation. J Nucl Med 43 5 (2002) 658-663
Scharko A.M., Perlman S.B., Hinds P.W., et al. Whole body positron emission tomography imaging of simian immunodeficiency virus-infected rhesus macaques. Proc Natl Acad Sci USA 93 13 (1996) 6425-6430
Gamelli R.L., Liu H., He L.K., et al. Augmentations of glucose uptake and glucose transporter-1 in macrophages following thermal injury and sepsis in mice. J Leukoc Biol 59 5 (1996) 639-647
Ahmed N., Kansara M., and Berridge M.V. Acute regulation of glucose transport in a monocyte-macrophage cell line: Glut-3 affinity for glucose is enhanced during the respiratory burst. Biochem J 327 Pt 2 (1997) 369-375
Jones H.A., Cadwallader K.A., White J.F., et al. Dissociation between respiratory burst activity and deoxyglucose uptake in human neutrophil granulocytes: implications for interpretation of (18)F-FDG PET images. J Nucl Med 43 5 (2002) 652-657
Paleolog E.M. Angiogenesis in rheumatoid arthritis. Arthritis Res 4 Suppl 3 (2002) S81-S90
Sasaki R., Komaki R., Macapinlac H., et al. [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. J Clin Oncol 23 6 (2005) 1136-1143
Borst G.R., Belderbos J.S., Boellaard R., et al. Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer. Eur J Cancer 41 11 (2005) 1533-1541
Downey R.J., Akhurst T., Gonen M., et al. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol 22 16 (2004) 3255-3260
Atkins C.D. Overestimation of the prognostic significance of SUV measurement by positron emission tomography for non-small-cell lung cancer. J Clin Oncol 23 27 (2005) 6799-6800
van Westreenen H.L., Plukker J.T., Cobben D.C., et al. Prognostic value of the standardized uptake value in esophageal cancer. AJR Am J Roentgenol 185 2 (2005) 436-440
Landewe R.B., and van der Heijde D.M. Early rheumatoid arthritis: toward tailor-made therapy. Curr Rheumatol Rep 5 4 (2003) 287-293
Ribbens C., Martin y Porras M., Franchimont N., et al. Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment. Ann Rheum Dis 61 2 (2002) 161-166
Taylor P.C., Steuer A., Gruber J., et al. Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis. Arthritis Rheum 50 4 (2004) 1107-1116
Wandler E., Kramer E.L., Sherman O., et al. Diffuse FDG shoulder uptake on PET is associated with clinical findings of osteoarthritis. AJR Am J Roentgenol 185 3 (2005) 797-803
El-Haddad G., Wolf M., Hochhold J., et al. The potential role of FDG-PET in the management of patients with osteoarthritic knees. J Nucl Med 42 Suppl 2 (2005) 182P
